WP
PRCT icon

Woodline Partners’s Procept Biorobotics PRCT Stock Holding History

Woodline Partners’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-65,000
Closed -$1.63M – 805
2021
Q4 		$1.63M Hold
65,000
– – 0.02% 443
2021
Q3 		$2.48M Buy
+65,000
New +$2.49M 0.04% 376

Other funds holding PRCT

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners's PRCT Position: Q1 2022 in Review

Woodline Partners sold out of Procept Biorobotics (PRCT) in Q1 2022, closing a stake of 65,000 shares — an estimated $1.63M sold.

Woodline Partners first reported a position in PRCT in Q3 2021 and held it in 2 quarters. The position peaked at $2.48M in Q3 2021. 58 funds tracked by Wall St. Rank hold PRCT as of Q1 2022.

  • Woodline Partners reported no remaining Procept Biorobotics position as of Q1 2022 after selling out during the quarter.
  • Woodline Partners sold 65,000 Procept Biorobotics shares in Q1 2022, an estimated $1.63M.
  • Woodline Partners first reported a position in Procept Biorobotics in Q3 2021 and held it in 2 quarters.
  • Woodline Partners's Procept Biorobotics position peaked at $2.48M in Q3 2021.
  • 58 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2022.

Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.